Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse von PUJADE-LAURAINE, Eric, WAGNER, Uwe, SEHOULI, Jalid, LORTHOLARY, Alain, KRISTENSEN, Gunnar, JACKISCH, Christian, JOLY, Florence, BROWN, Chris, LE FUR, Nathalie, DU BOIS, Andreas, AAVALL-LUNDQVIST, Elisabeth, GEBSKI, Val, HEYWOOD, Mark, VASEY, Paul A, VOLGGER, Birgit, VERGOTE, Ignace, PIGNATA, Sandro, FERRERO, Annamaria

Volltext

Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial von CRAWFORD, Simon C, VASEY, Paul A, PAUL, Jim, HAY, Andrea, DAVIS, Jo A, KAYE, Stan B

Volltext

The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients von GIFFORD, Gillian, PAUL, Jim, VASEY, Paul A, KAYE, Stanley B, BROWN, Robert

Volltext

Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Tria... von RUSTIN, Gordon J, MEAD, Graham M, STENNING, Sally P, VASEY, Paul A, AASS, Nina, HUDDART, Robert A, SOKAL, Michael P, JOFFE, Jonathan K, HARLAND, Stephen J, KIRK, Sarah J

Volltext

Role of Docetaxel in the Treatment of Newly Diagnosed Advanced Ovarian Cancer von Vasey, Paul A

Volltext

Phase III Randomized Trial of Docetaxel–Carboplatin Versus Paclitaxel–Carboplatin as First-line Chemotherapy for Ovarian Carcinoma von Vasey, Paul A., Jayson, Gordon C., Gordon, Alan, Gabra, Hani, Coleman, Rob, Atkinson, Ronnie, Parkin, David, Paul, James, Hay, Andrea, Kaye, Stan B.

Volltext

Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent von Burge, Matthew, Francesconi, Alessandra B., Kotasek, Dusan, Fida, Rosa, Smith, Gregg, Wilks, Andrew, Vasey, Paul A., Lickliter, Jason D.

Volltext

Part II: Testicular cancer—management of advanced disease von Jones, Robert H, Vasey, Paul A

Volltext

Part I: Testicular cancer—management of early disease von Jones, Robert H, Vasey, Paul A

Volltext

Cell cycle arrests and radiosensitivity of human tumor cell lines : dependence on wild-type p53 for radiosensitivity von MCILWRATH, A. J, VASEY, P. A, ROSS, G. M, BROWN, R

Volltext

Management of recurrent epithelial ovarian carcinoma von VASEY, Paul A.

Volltext

Microtubule Stabilization in the Treatment of Solid Tumors: Role of the Taxanes von Vasey, Paul A.

Volltext

Progress in the management of gynecologic cancer: consensus summary statement von Cannistra, Stephen A, Bast, Jr, Robert C, Berek, Jonathan S, Bookman, Michael A, Crum, Christopher P, DePriest, Paul D, Garber, Judy E, Koh, Wui-Jin, Markman, Maurie, McGuire, 3rd, William P, Rose, Peter G, Rowinsky, Eric K, Rustin, Gordon J S, Skates, Steven J, Vasey, Paul A, King, Laura

Volltext

Docetaxel in ovarian cancer: Phase III perspectives and future development von Kaye, Stanley B., Vasey, Paul A.

Volltext

Immunotherapy for renal carcinoma: theoretical basis and current standard of care von Vasey, Paul A.

Volltext

Concurrent presentation of Stage I teratoma and Stage I renal cell cancer von White, Jeff D., Seywright, Morag M., Aitchison, Michael, Vasey, Paul A.

Volltext

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin] : First member of a new class of chemotherapeutic agents-drug-polymer co... von VASEY, P. A, KAYE, S. B, BURTLES, S, FRAIER, D, FRIGERIO, E, CASSIDY, J, MORRISON, R, TWELVES, C, WILSON, P, DUNCAN, R, THOMSON, A. H, MURRAY, L. S, HILDITCH, T. E, MURRAY, T

Volltext

Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762) von VASEY, P. A, BISSETT, D, STROLIN-BENEDETTI, M, POGGESI, I, BREDA, M, ADAMS, L, WILSON, P, PACCIARINI, M. A, KAYE, S. B, CASSIDY, J

Volltext

“Dose dense” chemotherapy in ovarian cancer von VASEY, P.A.

Volltext

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial von Özgüroğlu, Mustafa, Mandalà, Mario, Ryu, Min-Hee, Olesiński, Tomasz, Mansoor, Wasat, Shacham-Shmueli, Einat, Chen, Xinqun, Kang, S Peter, Fuchs, Charles S, Lerzo, Guillermo, Lynam, James, Wong, Mark, Vasey, Paul, Van Laethem, Jean-Luc, Van Cutsem, Eric, Berry, Scott, Vincent, Mark, Muller, Bettina, Rey, Felipe, Zambrano, Angela, Guerra, Joaquin, Krogh, Merete, Yilmaz, Mette, Elme, Anneli, Auvinen, Paivi, Alanko, Tuomo, Moehler, Markus, Kunzmann, Volker, Hoehler, Thomas, Haag, Georg, Castro, Hugo, Aguilar Vasquez, Mynor, Cuffe, Sinead, Geva, Ravit, Hubert, Ayala, Beny, Alex, Giuseppe, Aprile, Passalacqua, Rodolfo, Montesarchio, Vincenzo, Chin, Keisho, Nishina, Tomohiro, Komatsu, Yoshito, Hironaka, Shuichi, Satoh, Taroh, Tamura, Takao, Sugimoto, Naotaoshi, Cho, Haruhiko, Omuro, Yashushi, Kato, Ken, Goto, Masahiro, Hyodo, Ichinosuke, Yoshida, Kazuhiro, Baba, Hideo, Esaki, Taito, Furuse, Junji, Wan Mohammed, Wan Zamaniah, Dominguez Andrade, Adriana, Glenjen, Nils, Kubiatowski, Tomasz, Jacek, Jassem, Wojtukiewicz, Marek, Lazarev, Sergey, Lancukhay, Yuri, Moiseyenko, Vladimir, Kostorov, Vladimir, Shirinkin, Vadim, Sakaeva, Dina, Fadeeva, Natalia, Yong, Wei Peng, Robertson, Barbara, Rapaport, Bernardo, Cohen, Graham, Dreosti, Lydia, Szpak, Waldemar, Roh, Sang-Young, Kim, Yeul Hong, Chung, Hyun Cheol, Ryu, Min-Hee, Longo Munoz, Federico, Cervantes Aguilar, Andres, Garcia Alfonso, Pilar, Feliu Batle, Jaime, Yeh, Kun-Huei, Chen, Jen-Shi, Chao, Yee, Kara, Oguz, Hochhauser, Daniel, Chau, Ian, Shaib, Walid, Philip, Philip, Sharma, Vivek, Sun, Weijing, George, Ben, Bullock, Andrea, Myrick, Samuel, Faruol, Josephine, Siegel, Richard, Becerra, Carlos, Richards, Donald A., Riche, Stephen L.

Volltext